217 related articles for article (PubMed ID: 31174878)
1. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.
Liss MA; Palazzi K; Stroup SP; Jabaji R; Raheem OA; Kane CJ
World J Urol; 2013 Jun; 31(3):481-8. PubMed ID: 23512231
[TBL] [Abstract][Full Text] [Related]
3. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
[TBL] [Abstract][Full Text] [Related]
4. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
5. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
[TBL] [Abstract][Full Text] [Related]
7. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
8. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
Eden CG; Arora A; Rouse P
BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
[TBL] [Abstract][Full Text] [Related]
9. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
[TBL] [Abstract][Full Text] [Related]
11. Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy.
Demir A; Karadağ MA; Türkeri L
Int Urol Nephrol; 2014 Aug; 46(8):1537-41. PubMed ID: 24664551
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
[TBL] [Abstract][Full Text] [Related]
13. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
14. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
15. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
[TBL] [Abstract][Full Text] [Related]
16. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
17. Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes.
Porpiglia F; De Luca S; Bertolo R; Passera R; Mele F; Manfredi M; Amparore D; Morra I; Fiori C
Int Braz J Urol; 2015; 41(6):1209-12019. PubMed ID: 26742982
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
19. Personalised indocyanine-guided lymphadenectomy for prostate cancer: a randomised clinical trial.
de Pablos-Rodríguez P; Claps F; Rebez G; Vidal Crespo N; Gómez-Ferrer Á; Mascarós JM; Collado Serra A; Caltrava Fons A; Rubio-Briones J; Casanova Ramon Borja J; Ramírez Backhaus M
BJU Int; 2023 Nov; 132(5):591-599. PubMed ID: 37410659
[TBL] [Abstract][Full Text] [Related]
20. Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy.
Bivalacqua TJ; Pierorazio PM; Gorin MA; Allaf ME; Carter HB; Walsh PC
Urology; 2013 Sep; 82(3):653-8. PubMed ID: 23987158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]